| Followers | 47 |
| Posts | 23588 |
| Boards Moderated | 0 |
| Alias Born | 09/16/2012 |
Tuesday, March 07, 2023 9:16:11 AM
Precisely. If this is all true how many poor retail investors buying the stock were knowingly manipulated as management sat back and watched for years? Even worse, as someone pointed out here, management never once bought on the open market during said period as their PR encouraged retail to do so! Imagine that as they collected options instead. But the unknown warrant holders were releasing plenty of converted shares.
Citadel and the rest are wholesalers. They stack up shares when the market gets flooded and there's no real buying. As
Much as you all want to avoid the conversation I can almost guarantee you they were stacking up shares the warrant holders were releasing into anemic legitimate buying. If Citadel chooses to open that door to discovery I believe they're entitled. My guess is this will all quietly go away as time goes on. Perhaps some small settlement with no admissions.
>>Citadel claims its “proprietary algorithms are designed to maximize efficiency by continuously optimizing order placement and accessing our principal liquidity.”
Citadel and the rest are wholesalers. They stack up shares when the market gets flooded and there's no real buying. As
Much as you all want to avoid the conversation I can almost guarantee you they were stacking up shares the warrant holders were releasing into anemic legitimate buying. If Citadel chooses to open that door to discovery I believe they're entitled. My guess is this will all quietly go away as time goes on. Perhaps some small settlement with no admissions.
>>Citadel claims its “proprietary algorithms are designed to maximize efficiency by continuously optimizing order placement and accessing our principal liquidity.”
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
